BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Rui Cao, Wenping Song, Cheng Ye, Xiujun Liu, Liang Li, Yi Li, Hongjuan Yao, Xiaofei Zhou, Liang Li, Rongguang Shao. Internal enhancement of DNA damage by a novel bispecific antibody-drug conjugate-like therapeutics via blockage of mTOR and PD-L1 signal pathways in pancreatic cancerCancer Medicine 2019; 8(2): 643 doi: 10.1002/cam4.1974
2
Barbara Burgos-Blasco, Samuel Hernandez-Ruiz, Lorenzo Lopez-Guajardo, Juan Donate-Lopez. Dexamethasone intravitreal implant in cystoid macular edema secondary to paclitaxel therapyAmerican Journal of Ophthalmology Case Reports 2020; 18: 100653 doi: 10.1016/j.ajoc.2020.100653
3
Diane Bressand, Anthony Novell, Alban Girault, William Raoul, Gaëlle Fromont-Hankard, Jean-Michel Escoffre, Thierry Lecomte, Ayache Bouakaz. Enhancing Nab-Paclitaxel Delivery Using Microbubble-Assisted Ultrasound in a Pancreatic Cancer ModelMolecular Pharmaceutics 2019; 16(9): 3814 doi: 10.1021/acs.molpharmaceut.9b00416
4
Masahiro Yasunaga, Shino Manabe, Masaru Furuta, Koretsugu Ogata, Yoshikatsu Koga, Hiroki Takashima, Toshirou Nishida, Yasuhiro Matsumura. Mass spectrometry imaging for early discovery and development of cancer drugsAIMS Medical Science 2018; 5(2): 162 doi: 10.3934/medsci.2018.2.162
5
Jianwen Zhou, Mingshuang Sun, Shanshan Jin, Li Fan, Wenquan Zhu, Xiaoyu Sui, Lixin Cao, Chunrong Yang, Cuiyan Han. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cellsDrug Delivery 2019; 26(1): 281 doi: 10.1080/10717544.2019.1580799
6
Jungwhoi Lee, Jungsul Lee, Woogwang Sim, Jae-Hoon Kim. Differential Dependency of Human Pancreatic Cancer Cells on Targeting PTEN via PLK 1 ExpressionCancers 2020; 12(2): 277 doi: 10.3390/cancers12020277
7
Paola Parente, Pietro Parcesepe, Claudia Covelli, Nunzio Olivieri, Andrea Remo, Massimo Pancione, Tiziana Pia Latiano, Paolo Graziano, Evaristo Maiello, Guido Giordano. Crosstalk between the Tumor Microenvironment and Immune System in Pancreatic Ductal Adenocarcinoma: Potential Targets for New Therapeutic ApproachesGastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/7530619
8
Johannes Byrling, Agata Sasor, Johan Nilsson, Katarzyna Said Hilmersson, Roland Andersson, Bodil Andersson. Expression of peritumoral SPARC during distal cholangiocarcinoma progression and correlation with outcomeScandinavian Journal of Gastroenterology 2020; 55(6): 725 doi: 10.1080/00365521.2020.1774923
9
Ulrich M. Lauer, Can Yurttas, Julia Beil. Cancer Regional Therapy2020; : 17 doi: 10.1007/978-3-030-28891-4_2
10
Sarah L. Skoczen, Kelsie S. Snapp, Rachael M. Crist, Darby Kozak, Xiaohui Jiang, Hao Liu, Stephan T. Stern. Distinguishing Pharmacokinetics of Marketed Nanomedicine Formulations Using a Stable Isotope Tracer AssayACS Pharmacology & Translational Science 2020; 3(3): 547 doi: 10.1021/acsptsci.0c00011
11
Rujing Chen, Leaf Huang, Kaili Hu. Natural products remodel cancer-associated fibroblasts in desmoplastic tumorsActa Pharmaceutica Sinica B 2020;  doi: 10.1016/j.apsb.2020.04.005
12
Tianqi Su, Bo Yang, Tianren Gao, Tongjun Liu, Jiannan Li. Polymer nanoparticle-assisted chemotherapy of pancreatic cancerTherapeutic Advances in Medical Oncology 2020; 12: 175883592091597 doi: 10.1177/1758835920915978
13
Takashi Murakami, Yukihiko Hiroshima, Ryusei Matsuyama, Yuki Homma, Robert M. Hoffman, Itaru Endo. Role of the tumor microenvironment in pancreatic cancerAnnals of Gastroenterological Surgery 2019; 3(2): 130 doi: 10.1002/ags3.12225
14
Ishfaq Ahmed, Sam G. Pappas, Ashiq Masood. Animal Models in Cancer Drug Discovery2019; : 267 doi: 10.1016/B978-0-12-814704-7.00011-8
15
Pengcheng Zhang, He Tao, Liyang Yu, Lixiao Zhou, Chenggang Zhu. Developing protein arginine methyltransferase 1 (PRMT1) inhibitor TC-E-5003 as an antitumor drug using INEI drug delivery systemsDrug Delivery 2020; 27(1): 491 doi: 10.1080/10717544.2020.1745327
16
Shu Ming Chai, Ser Yee Lee. High Endothelial Venules and Pancreatic Ductal Adenocarcinoma: A potential game changerEBioMedicine 2019; 39: 29 doi: 10.1016/j.ebiom.2018.11.061
17
Cheng Qin, Gang Yang, Jinshou Yang, Bo Ren, Huanyu Wang, Guangyu Chen, Fangyu Zhao, Lei You, Weibin Wang, Yupei Zhao. Metabolism of pancreatic cancer: paving the way to better anticancer strategiesMolecular Cancer 2020; 19(1) doi: 10.1186/s12943-020-01169-7
18
Haonan Li, Runwei Jiao, Jiahui Mu, Shengtao Xu, Xu Li, Xianhua Wang, Zhanlin Li, Jinyi Xu, Huiming Hua, Dahong Li. Bioactive Natural Spirolactone-Type 6,7-seco-ent-Kaurane Diterpenoids and Synthetic DerivativesMolecules 2018; 23(11): 2914 doi: 10.3390/molecules23112914
19
Anita Thyagarajan, Mamdouh Salman A. Alshehri, Kelly L.R. Miller, Catherine M. Sherwin, Jeffrey B. Travers, Ravi P. Sahu. Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic ApproachesCancers 2019; 11(11): 1627 doi: 10.3390/cancers11111627
20
Wen-Quan Wang, Liang Liu, Jin-Zhi Xu, Xian-Jun Yu. Reflections on depletion of tumor stroma in pancreatic cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2019; 1871(2): 267 doi: 10.1016/j.bbcan.2019.01.007
21
Lukas M. Braun, Simon Lagies, Jessica Guenzle, Stefan Fichtner-Feigl, Uwe A. Wittel, Bernd Kammerer. Metabolic Adaptation during nab-Paclitaxel Resistance in Pancreatic Cancer Cell LinesCells 2020; 9(5): 1251 doi: 10.3390/cells9051251
22
Si Shi, Chen Liang, Jin Xu, Qingcai Meng, Jie Hua, Xiujiang Yang, Quanxing Ni, Xianjun Yu. The Strain Ratio as Obtained by Endoscopic Ultrasonography Elastography Correlates With the Stroma Proportion and the Prognosis of Local Pancreatic CancerAnnals of Surgery 2020; 271(3): 559 doi: 10.1097/SLA.0000000000002998
23
Zhengliang Zhang, Xiangming Che, Ni Yang, Zhenghai Bai, Yuan Wu, Li Zhao, Honghong Pei. miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2Biomedicine & Pharmacotherapy 2017; 96: 1341 doi: 10.1016/j.biopha.2017.11.074
24
Johannes Betge, Jing Chi-Kern, Nadine Schulte, Sebastian Belle, Tobias Gutting, Elke Burgermeister, Ralf Jesenofsky, Martin Maenz, Ulrich Wedding, Matthias P. Ebert, Nicolai Haertel. A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4665-2